BERLIN (Reuters) - George Soros’s Open Society Foundations, best known for funding civil rights activists across Eastern Europe and the developing world, are increasingly turning...
Keep Reading →
June 20 - Hedge Funds, Insider Trading - Comments
Seeing as how several stocks are on the move due to earnings today, let's take a look at some of the more notable ones, including that of Exelixis Inc.
Keep Reading →
November 2 - News - Comments
Billionaire hedge fund manager David Tepper has reached a deal to buy the Carolina Panthers, the National Football League team announced Wednesday.
Keep Reading →
May 16 - Hedge Funds, Insider Trading - Comments
The biotech sector is well known for its M&A activity, but billionaire fund managers don’t seem to be attracted by the frenzy.
Keep Reading →
February 5 - Hedge Funds, News - Comments
"U.S. equities traded higher on Friday as concerns about Donald Trump's presidency recede for the time being.
Keep Reading →
May 19 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years.
Keep Reading →
November 24 - Hedge Fund Analysis, Hedge Funds, News - Comments
Among individual stocks that are showing more volatility today, are Deere & Company (NYSE:DE), Gas Natural Inc. (NYSEMKT:EGAS), Exelixis Inc.
Keep Reading →
October 10 - Market Movers, News - Comments
All three index futures are pointing north in pre-market trading as the Bank of England just announced that it would cut interest rates for the first time in seven years, to ...
Keep Reading →
August 4 - Earnings Report, Market Movers, News - Comments
Seeing as how the S&P 500 and the Dow Jones are near record highs, it's not surprising that many stocks have recently hit 52-week highs as well.
Keep Reading →
July 21 - Market Movers, News, Tech - Comments
It's been a pretty good day on Wall Street so far as the Dow Jones Index is up almost 100 points and all three major indexes are in the green.
Keep Reading →
June 6 - Market Movers, News - Comments
The Dow Jones is slightly in the red today as market sentiment dips on a more mixed batch of earnings results being released today. Origin Agritech Ltd.
Keep Reading →
April 26 - Market Movers, News - Comments
The key technical levels of 18,000 for the Dow and 2,100 for the S&P seem out of reach today as each index is in the red on the back of disappointing earnings reported by several...
Keep Reading →
April 22 - Market Movers, News - Comments
Wall Street has recorded moderate gains on the first day of March, with crude prices being the main catalyst for the stock exchanges. Meanwhile, there are several stocks gaining...
Keep Reading →
March 1 - Market Movers, News - Comments
The shares of Exelixis, Inc. (NASDAQ:EXEL) have jumped by 3.01% in today's trading session, as the company announced the first regulatory approval for Cobimetinib.
Keep Reading →
August 27 - Hedge Funds, News - Comments
According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected to die from the disease...
Keep Reading →
September 23 - News - Comments
The small patient pool for medullary thyroid cancer, or MTC, isn't going to move the needle for a large pharmaceutical company. But Exelixis, Inc.
Keep Reading →
September 17 - News - Comments
Shaw is known as a math wizard, and a quantitative investing pioneer.
Keep Reading →
September 10 - News - Comments
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Keep Reading →
September 4 - News - Comments
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Keep Reading →
September 3 - News - Comments
To the average investor, there are dozens of indicators market participants can use to analyze their holdings.
Keep Reading →
August 30 - News - Comments
In today’s marketplace, there are tons of gauges market participants can use to track their holdings.
Keep Reading →
August 28 - News - Comments
In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc.
Keep Reading →
August 23 - News - Comments
Small cap stocks are a bit riskier, but offer more growth than the stable large cap ones. The biotech sector in U.S.
Keep Reading →
July 17 - News - Comments
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
Keep Reading →
June 10 - News - Comments
To most stock holders, hedge funds are seen as underperforming, old financial tools of years past.
Keep Reading →
June 3 - News - Comments
The American Society of Clinical Oncology annual meeting kicks off today.
Keep Reading →
June 3 - News - Comments
Over the past three months, we've taken a deep dive into the 12 cancer types most likely to be diagnosed in the U.S.
Keep Reading →
June 3 - News - Comments
Shaw is known as a math wizard, and a quantitative investing pioneer. His firm is reportedly extremely selective, hiring less than 1% of applicants -- and Amazon.com, Inc.
Keep Reading →
May 31 - Hedge Funds - Comments
Today, let's look at SAC Capital Advisors, run by Steven Cohen.
Keep Reading →
May 28 - Hedge Funds - Comments
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Keep Reading →
May 8 - News - Comments
As I noted eight weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
April 29 - News - Comments
If you're going through life assuming that there isn't much difference between a traditional IRA and a Roth IRA, you're doing yourself a great disservice -- because the Roth IRA...
Keep Reading →
April 24 - News - Comments
According to most investors, hedge funds are perceived as worthless, old financial tools of years past.
Keep Reading →
April 8 - News - Comments
Today, let's look at Passport Capital, which was founded by John Burbank in 2000 and known for combining macroeconomic analysis and fundamental research.
Keep Reading →
March 20 - Hedge Funds - Comments
As I commented last week, cancer statistics are both staggering and disappointing.
Keep Reading →
March 5 - News - Comments
Celgene Corporation (NASDAQ:CELG) announced on Wednesday a $600 million deal to buy a stake in a growing biotech with several successful products on the market and a strong pipeline...
Keep Reading →
February 20 - News - Comments
Earnings are once again going to steal the spotlight this week, with four of the five can't-miss stories in the health-care sector revolving around earnings reports.
Keep Reading →
February 18 - News - Comments
Despite the rosy State of the Union address on Tuesday, consumers are still coping with the ramifications of the end of the payroll tax stimulus that has seen take-home pay shrink...
Keep Reading →
February 15 - News - Comments
With no major health-care conferences on the docket this week, and the Food and Drug Administration ruling two days early on Celgene Corporation (NASDAQ:CELG)'s multiple myeloma...
Keep Reading →
February 11 - News - Comments
Giant pharmaceutical companies are looking for the next big drug, and so are much smaller biotech outfits.
Keep Reading →
January 22 - News - Comments
